BioStrand Competitors and Similar CompaniesClear all
Apertura Gene Therapy's competitors and similar companies include Bluebird Bio and SpliceBio.
 Apertura Gene Therapy Apertura Gene Therapy is a biotech company creating technology for treating debilitating diseases with limited options for patients. |  SpliceBio SpliceBio (formerly known as ProteoDesign) is a biotechnology company developing gene therapies. | ||
Founding Date | Founding Date 2021 | Founding Date 1992 | Founding Date 2012 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations New York, US HQ | Locations Somerville, US HQ | Locations Barcelona, ES HQ |
Employees | Employees 11 | Employees 32338% decrease | Employees 452% decrease |
Funding | |||
Latest funding round | Latest funding round $ 67m (about 4 years ago) | Latest funding round N/A | Latest funding round $ 2m (over 8 years ago) |
Total funding raised | Total funding raised $ 67m | Total funding raised $ 409m | Total funding raised $ 2m |
For sources of this data, please see the company profile
View Company Profiles
Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
View companySpliceBio
HQ
Barcelona, ES
Employees
45↓ 2% decrease
SpliceBio (formerly known as ProteoDesign) is a biotechnology company developing gene therapies.
View company